Credit Suisse underwriting loan for Galenica acquisition

Credit Suisse is the sole underwriter of a bridge facility for Galenica's $1.53bn acquisition of US biopharmaceuticals firm Relypsa, the acquirer said on Thursday.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: